AAAAAA

   
Results: 1-9 |
Results: 9
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications
Authors: Joseph, PM O'Sullivan, B Lapey, A Dorkin, H Oren, J Balfour, R Perricone, MA Rosenberg, M Wadsworth, SC Smith, AE St George, JA Meeker, DP
Citation: Pm. Joseph et al., Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications, HUM GENE TH, 12(11), 2001, pp. 1369-1382
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
Authors: Perricone, MA Morris, JE Pavelka, K Plog, MS O'Sullivan, BP Joseph, PM Dorkin, H Lapey, A Balfour, R Meeker, DP Smith, AE Wadsworth, SC St George, JA
Citation: Ma. Perricone et al., Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium, HUM GENE TH, 12(11), 2001, pp. 1383-1394
Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates
Authors: Scaria, A Sullivan, JA George, JAS Kaplan, JM Lukason, MJ Morris, JE Plog, M Nicolette, C Gregory, RJ Wadsworth, SC
Citation: A. Scaria et al., Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates, MOL THER, 2(5), 2000, pp. 505-514
Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV)
Authors: O'Riordan, CR Lachapelle, AL Vincent, KA Wadsworth, SC
Citation: Cr. O'Riordan et al., Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV), J GENE MED, 2(6), 2000, pp. 444-454
PEGylation of adenovirus with retention of infectivity and protection fromneutralizing antibody in vitro and in vivo
Authors: O'Riordan, CR Lachapelle, A Delgado, C Parkes, V Wadsworth, SC Smith, AE Francis, GE
Citation: Cr. O'Riordan et al., PEGylation of adenovirus with retention of infectivity and protection fromneutralizing antibody in vitro and in vivo, HUM GENE TH, 10(8), 1999, pp. 1349-1358
Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells of choice
Authors: Romanczuk, H Galer, CE Zabner, J Barsomian, G Wadsworth, SC O'Riordan, CR
Citation: H. Romanczuk et al., Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells of choice, HUM GENE TH, 10(16), 1999, pp. 2615-2626
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium
Authors: Kitson, C Angel, B Judd, D Rothery, S Severs, NJ Dewar, A Huang, L Wadsworth, SC Cheng, SH Geddes, DM Alton, EWFW
Citation: C. Kitson et al., The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium, GENE THER, 6(4), 1999, pp. 534-546
E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors
Authors: Armentano, D Smith, MP Sookdeo, CC Zabner, J Perricone, MA St George, JA Wadsworth, SC Gregory, RJ
Citation: D. Armentano et al., E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors, J VIROLOGY, 73(8), 1999, pp. 7031-7034
Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes
Authors: Kaplan, JM Armentano, D Scaria, A Woodworth, LA Pennington, SE Wadsworth, SC Smith, AE Gregory, RJ
Citation: Jm. Kaplan et al., Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes, J VIROLOGY, 73(5), 1999, pp. 4489-4492
Risultati: 1-9 |